BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 26, 2010
 |  BC Week In Review  |  Company News  |  Deals

4SC, Nexigen deal

The companies partnered to develop peptide therapies to treat cancer linked to the Wnt signaling pathway. Nexigen will use...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >